Table II.
Exp # a | % Specific LC loss b | % Specific Apoptosis c | % Specific LC Death | |||
---|---|---|---|---|---|---|
WTd | Bid KO | WT | Bd KO | WT | Bd KO | |
1 | 46.7 | 0.5 | 21.0 | 2.0 | 67.7 | 2.5 |
2 | 47.4 | 5.0 | 12.7 | 3.0 | 60.1 | 8.0 |
3 | 30.4 | 7.4 | 16.0 | 0.0 | 46.4 | 7.4 |
| ||||||
Average | 41.5 | 4.3 | 16.6 | 1.7 | 58.1 | 6.0 |
St Dev | 9.6 | 3.5 | 4.2 | 1.5 | 10.8 | 3.0 |
P <e | 0.02 | 0.02 | 0.01 |
Results from three independent experiments are shown. cDCs were gated for each experiment as follows: Exp # 1, I-A; Exp # 2, CD11c; Exp # 3, Langerin (CD207). WT or Bid KO LCs comprises the majority of cDCs isolated from ear skin cultures, as described in Materials and Methods.
% Specific LC loss is calculated as the difference in percent of LCs remaining after overnight culture in the presence of OVA antigen and relevant OT-2 versus irrelevant 3A9 naïve purified CD4 T cells .
% Specific Apoptosis is calculated as the difference in apoptosis detected by annexin V and/or 7-AAD staining of remaining DCs after overnight culture in the presence of OT-2 or 3A9 T cells.
% Specific LC Death = % Specific LC loss + % Specific Apoptosis.
P values were determined using a one-tailed, paired Student’s t-test.